GlassScriptPhysician profile
Jeffrey D Jackson
NPI 1033123179
$2,283,356.71
in general payments reported to CMS, 2019-2025
11 companies · $339K in 2025
The $339K reported for 2025 was more than what 99% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18K · 2020: $86K · 2021: $239K · 2022: $480K · 2023: $651K · 2024: $469K · 2025: $339K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $1.4M · Consulting Fee: $6,535 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,000 · Travel and Lodging: $1,477 · Food and Beverage: $852 · Education: $73.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $1,446,710.49 |
| Consulting Fee | $6,534.69 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,000.00 |
| Travel and Lodging | $1,476.53 |
| Food and Beverage | $851.51 |
| Education | $73.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $2,280,282.47 | 2019-2025 | Arthrex |
| Active Medical, LLC | $1,209.41 | 2019-2025 | |
| Smith+Nephew, INC. | $706.24 | 2019-2023 | Anthology, Real Intelligence |
| Stryker Corporation | $580.73 | 2019-2025 | Tornier Perform Reversed Glenoid, Gamma, Blueprint Patient Specific Instrumentation |
| Zimmer Biomet Holdings, INC. | $173.48 | 2020-2025 | Comprehensive, Persona, Comprehensive Shoulder System |
| Vericel Corporation | $161.71 | 2023-2024 | Maci |
| Depuy Synthes Sales INC. | $125.88 | 2021-2023 | Tfn-Advance |
| Corium, LLC | $48.34 | 2025 | Azstarys |
| Orthofix Medical, INC. | $29.67 | 2025 | Physio-Stim |
| Heron Therapeutics, INC. | $27.24 | 2024 | Zynrelef |
| Tris Pharma INC | $11.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.